Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

OTHER 62 INDUSTRY 42 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 33 Prostatic Neoplasms 26 Neoplasms 22 Colonic Neoplasms 12 Lung Neoplasms 10 Colonic Polyps 10 Breast Neoplasms 10 Rare Diseases 8 Adenoma 6 Pulmonary Disease, Chronic Obstructive 5 Heart Failure 5 Rectal Neoplasms 4 Ovarian Neoplasms 4 Pain 3 Mental Disorders 3 Death 3 Adenomatous Polyps 3 Uterine Cervical Neoplasms 2 Urinary Incontinence 2 Smoking Cessation 2 Skin Neoplasms 2 Sezary Syndrome 2 Respiratory Aspiration 2 Renal Insufficiency, Chronic 2 Polycystic Ovary Syndrome 2 Patient Preference 2 Patient Compliance 2 Obesity 2 Neurologic Manifestations 2 Neurofibromatosis 2 2

Interventions

Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × FED × Myasthenia Gravis × Clear all

NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡